Martin Avenue Pharmacy, Inc.
Complete recall history across all FDA and CPSC categories — 118 total recalls
Martin Avenue Pharmacy, Inc. appears in recall records across 1 category. This page consolidates all FDA food, drug, and medical device enforcement actions, plus CPSC consumer product recalls associated with this company. Recall data is sourced from openFDA and CPSC public databases.
Drug Recalls (118)
FDA drug safety enforcement actions by Martin Avenue Pharmacy, Inc.. Showing most recent 50.
| Date | Product | Reason | Class |
|---|---|---|---|
| Aug 27, 2014 | Dihydroergotamine mesylate 1 mg/mL injection solution packaged in an amber gl... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a ... | Class II |
| Aug 27, 2014 | Nalbuphine 10 mg/mL injection solution packaged in an amber glass injectable ... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a ... | Class II |
| Aug 27, 2014 | Fentanyl/bupivacaine 3000 mcg/30 mg/mL injectable packaged in 30 mL or 60 mL ... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a ... | Class II |
| Aug 27, 2014 | Tri-mix, 15 mg/0.5 mg/10 mcg/mL (papaverine, phentolamine mesylate, alprostad... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a ... | Class II |
| Aug 27, 2014 | Bacteriostatic water for injection packaged in an amber glass injectable vial... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a ... | Class II |
| Aug 27, 2014 | Prednisolone acetate 50 mg/mL injectable packaged in an amber glass injectabl... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a ... | Class II |
| Aug 27, 2014 | Tri-mix T106, 30 mg/1 mg/25 mcg/mL (papaverine, phentolamine mesylate, alpros... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a ... | Class II |
| Aug 27, 2014 | Bupivacaine hydrochloride 0.25% injectable packaged in an amber glass injecta... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a ... | Class II |
| Aug 27, 2014 | Triamcinolone acetonide (PF) 40 mg/mL injection suspension packaged in an amb... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a ... | Class II |
| Aug 27, 2014 | Sodium tetradecyl sulfate 2% (PF) injectable packaged in an amber glass injec... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a ... | Class II |
| Aug 27, 2014 | Hydromorphone/bupivacaine (PF) 0.5 mg/0.2 mg/mL injectable packaged in 30 mL ... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a ... | Class II |
| Aug 27, 2014 | Tri-mix T25, 4.413 mg/0.145 mg/1.475 mcg/mL (papaverine, phentolamine mesylat... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a ... | Class II |
| Aug 27, 2014 | Calcium chloride (PF) 100 mg/mL injectable packaged in an amber glass injecta... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a ... | Class II |
| Aug 27, 2014 | Cyclosporine/corn oil stock vehicle oil packaged in an amber glass injectable... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a ... | Class II |
| Aug 27, 2014 | Histamine 2.75 mg/mL injectable packaged in an amber glass injectable vial, M... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a ... | Class II |
| Aug 27, 2014 | Cefazolin forte 25 mg/mL opthalmic solution packaged in an opaque squeeze bot... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a ... | Class II |
| Aug 27, 2014 | Chlorhexidine gluconate 0.02% opthalmic solution packaged in an opaque squeez... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a ... | Class II |
| Aug 27, 2014 | Pilocarpine (PF) 0.25% opthalmic solution packaged in an opaque squeeze bottl... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a ... | Class II |
| Aug 27, 2014 | Tri-mix, 30 mg/2 mg/20 mcg/mL (papaverine, phentolamine mesylate, alprostadil... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a ... | Class II |
| Aug 27, 2014 | Tri-mix, 12 mg/1 mg/9 mcg/mL (papaverine, phentolamine mesylate, alprostadil)... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a ... | Class II |
| Aug 27, 2014 | Tri-mix ST9-A, 30 mg/2 mg/80 mcg/mL (papaverine, phentolamine mesylate, alpro... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a ... | Class II |
| Aug 27, 2014 | Hydroxocobalamin 5 mg/mL injectable packaged in an amber glass injectable via... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a ... | Class II |
| Aug 27, 2014 | PGE 1, 40 mcg/mL injectable packaged in a clear glass injectable vial, Martin... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a ... | Class II |
| Aug 27, 2014 | Lidocaine 2% injectable packaged in an amber glass injectable vial, Martin Av... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a ... | Class II |
| Aug 27, 2014 | Diazepam 5 mg/mL injectable packaged in an amber glass injectable vial, Marti... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a ... | Class II |
| Aug 27, 2014 | Cefazolin forte 50 mg/mL opthalmic solution packaged in an opaque squeeze bot... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a ... | Class II |
| Aug 27, 2014 | Cyanocobalamin 1000 mcg/mL injectable solution packaged in an amber glass inj... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a ... | Class II |
| Aug 27, 2014 | PGE 2, 100 mcg/mL injectable packaged in a clear glass injectable vial, Marti... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a ... | Class II |
| Aug 27, 2014 | Acetylcysteine 10% opthalmic solution packaged in an opaque squeeze bottle ey... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a ... | Class II |
| Aug 27, 2014 | Tri-mix, 30 mg/2 mg/10 mcg/mL (papaverine, phentolamine mesylate, alprostadil... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a ... | Class II |
| Aug 27, 2014 | Cyclosporine 200 mg/mL opthalmic suspension packaged in an amber glass inject... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a ... | Class II |
| Aug 27, 2014 | Polyhexamethylene biguanide 0.02% opthalmic solution packaged in an opaque sq... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a ... | Class II |
| Aug 27, 2014 | Quad mix 1, 12 mg/1 mg/10 mcg/0.15 mg/mL (papaverine, phentolamine mesylate, ... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a ... | Class II |
| Aug 27, 2014 | Trimethoprim/sulfadiazine excipient stock solution injection packaged in an a... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a ... | Class II |
| Aug 27, 2014 | Polyhexamethylene biguanide 2% stock solution packaged in an opaque squeeze b... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a ... | Class II |
| Aug 27, 2014 | Acetylcysteine 20% (PF) inhalant solution packaged in either a 3 mL or 7 mL v... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a ... | Class II |
| Aug 27, 2014 | Tri-mix, 30 mg/0.5 mg/10 mcg/mL (papaverine, phentolamine mesylate, alprostad... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a ... | Class II |
| Aug 27, 2014 | Paraben water for injection packaged in a sterile 1000 mL clear bottle, Marti... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a ... | Class II |
| Aug 27, 2014 | Dexamethasone sodium phosphate 24 mg/mL injectable packaged in an amber glass... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a ... | Class II |
| Aug 27, 2014 | Tri-mix T102, 17.65 mg/0.59 mg/10 mcg/mL (papaverine, phentolamine mesylate, ... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a ... | Class II |
| Aug 27, 2014 | Peng/proc/strep/chlor/hyos (penicillin G, procaine, streptomycin sulfate, chl... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a ... | Class II |
| Aug 27, 2014 | Glycerin 72% (w/v) sodium chloride injectable packaged in an amber glass inje... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a ... | Class II |
| Aug 27, 2014 | Atropine sulfate 0.5% opthalmic solution packaged in a squeeze bottle eye dro... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a ... | Class II |
| Aug 27, 2014 | PGE 2.5, 150 mcg/mL injectable packaged in a clear glass injectable vial, Mar... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a ... | Class II |
| Aug 27, 2014 | Hydromorphone/clonidine/bupivacaine 12 mg/600 mcg/0.2 mg/mL injectable packag... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a ... | Class II |
| Aug 27, 2014 | Hydroxocobalamin 10 mg/mL injectable packaged in an amber glass injectable vi... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a ... | Class II |
| Aug 27, 2014 | Cromolyn sodium 1% inhalant solution packaged in a 3 mL or 7 mL vial, Martin... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a ... | Class II |
| Aug 27, 2014 | PGE 4, 300 mcg/mL injectable packaged in a clear glass injectable vial, Marti... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a ... | Class II |
| Aug 27, 2014 | Methylcobalamin (PF) 25 mg/mL injectable packaged in an amber glass injectabl... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a ... | Class II |
| Aug 27, 2014 | Vancomycin 25 mg/mL opthalmic solution packaged in an opaque squeeze bottle e... | Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a ... | Class II |
Frequently Asked Questions
A high number of recalls does not necessarily indicate that a company is unsafe. Large manufacturers that produce thousands of products across multiple categories will statistically appear in recall databases more frequently. What matters more is the severity of each recall (Class I being the most serious), the speed of response, and whether the company proactively identified and addressed the issue. Companies with robust safety programs often catch problems earlier.
Food, drug, and medical device recall data comes from the FDA's openFDA enforcement database, which contains all FDA enforcement reports. Consumer product recall data comes from the U.S. Consumer Product Safety Commission (CPSC). Both sources are public government databases that are updated regularly. RecallCheck aggregates these sources to provide a unified view of a company's recall history.
The FDA classifies recalls into three categories. Class I is the most serious — there is a reasonable probability that use of or exposure to the product will cause serious adverse health consequences or death. Class II means the product may cause temporary or medically reversible health problems, or the probability of serious consequences is remote. Class III is the least serious — the product is unlikely to cause adverse health consequences. CPSC product recalls do not use this classification system.
Yes. You can search for any company using the firm/manufacturer pages for each category: Food Firms, Drug Firms, Device Firms, or Product Manufacturers. You can also use the search functionality on any browse page to find recalls by company name.
Explore More Recalls
Search recalls by category, state, reason, or firm across all our databases.